| Appel d'offres Partiel Médicaments2022-0550-37-03 | Centre d'acquisitions gouvernementales | 203 k $ | 17 juin 2026 |
| Appel d'offres Partiel Médicaments2022-4777-47-02 | Centre d'acquisitions gouvernementales | 71 491,43 $ | 3 juin 2026 |
| HealthPRO Canada PHARMACY – PI26 BIOLOGICS AND BIOSIMILARSPI26BIOLOGICSANDBIOSIMILARS | HealthPro Procurement Services Inc. | — | 1 juin 2026 |
| FEBRUARY 2026 MARKET RESPONSE RFP FOR OFF PATENT, ONCOLOGY ITEMSFEBRUARY2026MARKETRESPONSERFPFOROFFPATENTONCOLOGYITEMS | HealthPro Procurement Services Inc. | 17 666 $ | 15 mai 2026 |
| FEBRUARY 2026 MARKET RESPONSE RFP FOR OFF PATENT, GENERAL TRADE PRODUCTSFEBRUARY2026MARKETRESPONSERFPFOROFFPATENTGENERALTRADEPRODUCTS | HealthPro Procurement Services Inc. | 67 $ | 15 mai 2026 |
| NOVEMBER 2025 MARKET RESPONSE RFP FOR OFF PATENT, GENERAL TRADE PRODUCTSNOVEMBER2025MARKETRESPONSERFPFOROFFPATENT,GENERALTRADEPRODUCTS | HealthPro Procurement Services Inc. | 22 573 $ | 15 févr. 2026 |
| JULY 2025 MARKET RESPONSE RFP FOR OFF PATENT, GENERAL TRADE PRODUCTSJULY2025MARKETRESPONSERFPFOROFFPATENT,GENERALTRADEPRODUCTS | HealthPro Procurement Services Inc. | 661 k $ | 15 oct. 2025 |
| Appel d'offres Partiel Médicaments2022-4777-46-02 | Centre d'acquisitions gouvernementales | 2,1 M $ | 5 juin 2025 |
| Médicaments - Partiel2022-0550-35-02 | Centre d'acquisitions gouvernementales | 1,5 M $ | 8 juill. 2024 |
| Médicaments - Partiel2022-0550-35-02 | Centre d'acquisitions gouvernementales | 1,5 M $ | 8 juill. 2024 |
| Médicaments - Partiel2023-3001-22-01 | Centre d'acquisitions gouvernementales | 2,2 M $ | 24 mai 2024 |
| Médicaments - Complémentaire2022-4777-45-01 | Centre d'acquisitions gouvernementales | 38 271 $ | 11 janv. 2024 |
| Médicaments - Complémentaire2022-4777-45-01 | Centre d'acquisitions gouvernementales | 38 271 $ | 11 janv. 2024 |
| Médicaments - Partiel2022-0550-34-02 | Centre d'acquisitions gouvernementales | 47,04 $ | 3 oct. 2023 |
| Produits pharmaceutiques génériques OCINCW2319030 | Department of Public Works and Government Services (PSPC) | 2,8 M $ | 27 juill. 2023 |
| Produits pharmaceutiques génériques OCINCW2319030 | Department of Public Works and Government Services (PSPC) | 2,8 M $ | 27 juill. 2023 |
| Produits pharmaceutiques génériques OCINCW2319030 | Department of Public Works and Government Services (PSPC) | 2,8 M $ | 27 juill. 2023 |
| Pharmaceutical and other medicinal products, PetawawaW6369-23-A056 | Department of National Defence | 129,6 k $ | 8 nov. 2022 |
| APOTEX INC (E60PH-22DRUG/001/PH~000)E60PH-22DRUG/001/PH | Public Works and Government Services Canada | 1,2 M $ | 9 sept. 2022 |
| Médicaments2022-4777-41-01 | Centre d'acquisitions gouvernementales - Direction du service à la clientèle et de l'exécution des contrats | 101,1 k $ | 22 déc. 2021 |
| APOTEX INC (E60PH-21ACEP/001/PH~000)E60PH-21ACEP/001/PH | Public Works and Government Services Canada | 443,2 k $ | 23 sept. 2021 |
| Drugs and BiologicalsH105104033 | Health Canada | 10,8 M $ | 19 janv. 2021 |
| APOTEX INC (H1051-204033/001/PH~001)H1051-204033/001/PH | Public Works and Government Services Canada | 9,6 M $ | 19 janv. 2021 |
| APOTEX INC (H1051-204033/001/PH~000)H1051-204033/001/PH | Public Works and Government Services Canada | 9,6 M $ | 19 janv. 2021 |
| Drugs and BiologicalsH105103782 | Health Canada | 19 754 $ | 16 déc. 2020 |
| APOTEX INC (H1051-203782/002/PH~001)H1051-203782/002/PH | Public Works and Government Services Canada | 21 754 $ | 14 déc. 2020 |
| APOTEX INC (H1051-203782/002/PH~000)H1051-203782/002/PH | Public Works and Government Services Canada | 21 754 $ | 14 déc. 2020 |
| Drugs and Biologicals6D0242122A | Public Health Agency of Canada | 497,2 k $ | 21 avr. 2020 |
| DRUGS,HUMAN4600021627 | Manitoba Finance | 135 k $ | 18 nov. 2019 |
| APOTEX INC (E60PH-19DRUG/001/PH~005)E60PH-19DRUG/001/PH | Public Works and Government Services Canada | 6,4 M $ | 25 juin 2019 |